Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1190 of 5804
-
Custom immune attack: new gene therapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New cocktail of drugs and radiation targets Hard-to-Treat sarcoma
Disease control Not yet recruitingThis study intends to enroll patients with advanced soft tissue sarcoma, employing immunotherapy combined with eribulin, anlotinib, and radiotherapy as subsequent-line treatment to preliminarily explore its efficacy and safety. QL1706, a dual-targeting agent against PD-1 and CTLA…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for lung cancer patients when first targeted drug stops working
Disease control Not yet recruitingThis is a multicenter, non-interventional, observational real-world study to evaluate the efficacy and safety of Taletrectinib in ROS1-positive non-small cell lung cancer (NSCLC) following Entrectinib progression. Patients deemed eligible for Taletrectinib by their physicians wer…
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hepatitis b drug enters human trials – could it help control the virus?
Disease control Recruiting nowThis is a Phase Ib/II, multicenter, randomized, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of LW231 in participants with chronic hepatitis B virus (HBV) infection. The trial will include multip…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New trial aims to outsmart cancer by adjusting chemo doses in real time
Disease control Recruiting nowThis phase II trial evaluates the effect of capecitabine on tumor response using imaging and tumor markers to adjust dose (adaptive therapy) in patients with estrogen receptor (ER) positive, HER2 negative breast cancer that has spread from where it first started to other areas in…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a deeper cleanup beat amyloidosis?
Knowledge-focused Not yet recruitingBefore effective treatment, the prognosis of patients with AL amyloidosis is very poor, with a median survival of approximately 12 months. In recent decades, with the development of new drugs, the treatment paradigm for AL amyloidosis has undergone significant changes, and the pr…
Phase: NA • Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New scan aims to spot breast cancer more accurately
Diagnosis Not yet recruitingBreast cancer is the most common type of cancer in Norwegian women, with 4,224 new cases in 2022. More precise diagnosis are expected to result in more accurate assessment of treatment effect, and to contribute to both providing better treatment and reducing overtreatment. Fibrob…
Phase: NA • Sponsor: St. Olavs Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 17:28 UTC
-
Simple urine test could spot pneumonia in kids without needles
Diagnosis Not yet recruitingBackground:Pneumonia caused by the bacteria Streptococcus pneumoniae is a leading cause of death among children under five years of age, especially in sub-Saharan Africa. Accurate diagnosis remains challenging due to the need for invasive procedures to obtain samples for culture-…
Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 18:04 UTC
-
New combo procedure aims to seal aortic tears more completely
Disease control Not yet recruitingThis multicenter, prospective, observational study aims to evaluate the efficacy and safety of thoracic endovascular aortic repair (TEVAR) combined with false lumen embolization using vascular plugs in patients with acute type B aortic dissection. Despite TEVAR being a standard t…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Earlier skull patch may boost brain healing
Disease control Not yet recruitingTo compare the neurological recovery and complication rate of autogenous cranioplasty(CP) within 6 weeks after decompressive craniectomy (DC) with that of autogenous cranioplasty within 3\~6 months after DC.
Phase: NA • Sponsor: The Affiliated Hospital Of Guizhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 19:15 UTC
-
Hope for severe asthma: study tests if biologics can heal lungs
Knowledge-focused Not yet recruitingIn this program of research, the investigators aim to answer the question: In patients with asthma aged 18-80, how do the lung airways and vessels respond to biologic therapy and what role does age and asthma duration have in this response? While about 4.6 million Canadians live …
Phase: NA • Sponsor: Western University, Canada • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:58 UTC
-
Fewer days of radiation may control brain tumors just as well
Disease control Not yet recruitingThe goal of this prospective, multi-center, randomized double-arm clinical trial is to demonstrate a benefit in term of local control of a shorter spread of hypofractionated stereotactic radiotherapy at D1-2-3 vs D1-3-5, in the treatment of "radioresistant" Brain Metastases (BM).…
Phase: PHASE3 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 26, 2026 16:49 UTC
-
Simple breathing workout may free ventilator patients faster
Disease control Not yet recruitingProlonged mechanical ventilation (PMV) and weaning failure can lead to extended hospital stays, as well as increased morbidity and mortality during hospitalization. Therefore, PMV not only increases the economic burden on patients and their families, but also adds to the societal…
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Single gel application may speed healing of diabetic foot wounds
Disease control Not yet recruitingThis multicenter, randomized controlled trial will evaluate the effectiveness and safety of DEBRICHEM®, a topical desiccant gel, when added to standard care for chronic diabetic foot wounds. Chronic diabetic foot ulcers affect up to 25% of people with diabetes and are associated …
Phase: NA • Sponsor: DEBx Medical B.V. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Brain zaps and scans: new hope for alcohol addiction?
Disease control Recruiting nowThe goal of this clinical study is to test the effectiveness of a supplemental fMRI neurofeedback and/or TMS intervention in individuals seeking treatment for Alcohol Use Disorder. After an initial visit, participants will come in once a week for four (4) weeks for an interventi…
Phase: NA • Sponsor: Auburn University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Smart brain implants tested to ease Parkinson's symptoms
Symptom relief Not yet recruitingThis multi-center pilot study compares conventional DBS (cDBS) and adaptive DBS (aDBS) in Parkinson's disease patients using the Medtronic Percept™ system. The aim of the study is to identify which patients benefit most from aDBS, and to explore patient and LFP signal characteri…
Phase: NA • Sponsor: HagaZiekenhuis • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New pill hopes to clear stubborn hand and foot blisters
Disease control Recruiting nowWhat's the problem? Palmoplantar pustulosis (PPP) is a long-term skin condition that mainly affects the palms of hands and soles of feet. It causes red, scaly skin with small, non-infectious blisters (called pustules), and often brings pain, itching, or even joint damage over tim…
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New pill hopes to tame ulcerative colitis in older adults
Disease control Recruiting nowEligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod ad…
Phase: NA • Sponsor: Showa Inan General Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
AI steps in to catch complications rheumatoid arthritis patients often miss
Diagnosis Recruiting nowGenerative AI (GenAI) based on large language models (LLMs) is expected to improve the diagnosis and treatment of autoimmune diseases. We are studying how GenAI may affect the diagnosis of various complications of rheumatoid arthritis (RA). In a retrospective study using RA patie…
Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New study: could a tiny camera help kids breathe better?
Disease control OngoingThis prospective RCT at Cairo University Children Hospitals enrolls critically ill pediatric patients (intubated, NIV, or post-extubation) with lung atelectasis unresponsive to 48 hours of conventional recruitment. Randomization uses computer-generated sealed envelopes: Group A r…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC